slides · global inventory
Compare Peers
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 9,820
Current window 6,871-6,900
Pages 328
Rows per page 30
Slide function
6,871-6,900 of 9,820
15
The chart uses a vertical axis to categorize drugs by mechanism of action (α4β7, IL-23s, TNFαs, S1P1s, JAKs) and a horizontal axis for efficacy (Pbo-adjusted clinical remission %).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
16
The table uses checkmarks for positive attributes and arrows for 'potential upside' to differentiate SPY001's superior profile.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
22
The slide uses a visual timeline/comparison to contrast the high injection frequency of the competitor with the lower frequency of SPY001.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
28
The chart compares clinical remission rates across different drug classes (TL1A, a4b7, IL-23s, TNFas, S1P1s, JAKs) with a safety gradient indicated on the Y-axis.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
29
Uses a checkmark matrix to highlight competitive advantages of SPY002.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
31
The slide uses a bar chart to compare efficacy and provides a strategic rationale for pursuing both monomeric/trimeric and trimeric-only approaches.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
32
Includes two charts: a dose-response curve and a scatter plot of potency vs. binding specificity.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
33
The table contrasts established drugs (with confirmed exposure-response) against newer anti-TL1A agents (PRA023, RVT-3101) where this relationship is currently TBD.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
39
The slide uses donut charts to represent remission rates and highlights the safety advantages of Spyre's gut-selective approach.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
47
The table uses a custom visualization for market cap range (min, IPO, today, max) and clinical stage progression.Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
48
The table maps historical industry M&A deals to Spyre's internal pipeline development milestones (2025-2027).Aeglea BioTherapeutics | Mergers and Acquisitions Presentation Deck | 50 slides · Aeglea BioTherapeutics
Deck Investment bank 1 hit
11
The slide uses three bar charts to demonstrate superior performance of ALKS relative to benchmarks.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Before After1 hit
12
The slide uses bar charts to demonstrate performance relative to an 'unaffected date' related to a shareholder activist event.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations Beat · Future Vision (Gain)Loop · Before After1 hit
40
This is a proxy fight slide comparing incumbent board members against challenger nominees.Alkermes | Investor Presentation Deck | 56 slides · Alkermes
Conference presentation Investor relations 1 hit
44
The slide uses a Kaplan-Meier curve for PFS and a forest plot for safety odds ratios.AstraZeneca | Investor Event Presentation Deck | 52 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
11
The slide uses a grid-based layout to contrast Azerion's vertical integration against fragmented competitors.Azerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations Beat · ProductLoop · Mece Breakdown1 hit
25
Azerion | Investor Conference Presentation Deck | 31 slidesAzerion | Investor Conference Presentation Deck | 31 slides · Azerion
Conference presentation Investor relations 1 hit
12
Bigbear AI | Investor Presentation Deck | 28 slidesBigbear AI | Investor Presentation Deck | 28 slides · BigBear.ai
Pitch deck Investor relations Beat · CompetitionLoop · Cost Of Inaction1 hit
46
The iShares bar is segmented into Strategic, Core Equity, and Precision ETFs.BlackRock | Investor Day Presentation Deck | 138 slides · BlackRock
Conference presentation Investor relations 1 hit
117
The slide highlights BlackRock's specific growth targets in contrast to industry benchmarks.BlackRock | Investor Day Presentation Deck | 138 slides · BlackRock
Conference presentation Investor relations 1 hit
10
The slide uses a stacked bar chart to visualize market share distribution among competitors.Diageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations Beat · Interest1 hit
49
The slide highlights market dominance and growth contribution.Diageo | Investor Event Presentation Deck | 63 slides · Diageo
Conference presentation Investor relations 1 hit
09
The chart uses a horizontal bar format to contrast the US against other OECD nations and the average.DocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · Early Struggles1 hit
11
Uses a dot-plot style visualization to show relative performance between 'Worst' and 'Best' benchmarks.DocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · Early StrugglesLoop · Cost Of Inaction1 hit
45
DocGo | Investor Day Presentation Deck | 119 slidesDocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · Rising Success1 hit
81
Uses a split-screen layout to contrast industry standards with the company's specific advantages.DocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
112
The slide uses a matrix to highlight that DocGo covers all listed service categories, whereas competitors have gaps.DocGo | Investor Day Presentation Deck | 119 slides · DocGo
Conference presentation Investor relations Beat · Ultimate Achievement1 hit
34
The slide uses a comparison frame to suggest Doximity has significant growth potential by benchmarking against M3's higher revenue per doctor.Doximity | Investor Day Presentation Deck | 56 slides · Doximity
Conference presentation Investor relations 1 hit
10
The slide uses a hub-and-spoke diagram to illustrate market positioning relative to competitors in four distinct categories.Dragonfly Energy | Investor Presentation Deck | 25 slides · Dragonfly Energy
Pitch deck Investor relations 1 hit
06
The table uses a highlight box to emphasize the EWC column.European Wax Center | Investor Presentation Deck | 25 slides · European Wax Center
Pitch deck Investor relations 1 hit